is tirzepatide being discontinued In a 69-year-old man who discontinued tirzepatide (Zepbound) after six months and now has worsening depression and concerns about weight regain, what pharmacologic The Tirzepatide Shortage Is Over:

If another person receives a needle stick with a used needle, that person should be told to contact a healthcare provider right away

Abbreviations AACE/ACE: American Association of Clinical Endocrinologists/American College of Endocrinology ADA: American Diabetes Association ASCVD: Atherosclerotic cardiovascular disease AUC: Area under the curve C avg : Average plasma concentration CI: Confidence interval C max : Maximum concentration CV: Cardiovascular CVD: Cardiovascular disease CVOT: Cardiovascular outcomes trial DPP-4: Dipeptidyl peptidase-4 empa: empagliflozin ETD: Estimated treatment difference FDA: Food and Drug Administration GI: Gastrointestinal GLP-1: Glucagon-like peptide-1 GLP-1RA: Glucagon-like peptide-1 receptor agonist GRAS: Generally regarded as safe HbA 1c : Glycated hemoglobin HR: Hazard ratio imp.: impairment lira: liraglutide MACE: Major adverse cardiovascular events met: metformin OAD: Oral antidiabetes drug pbo: placebo s.c.: subcutaneous sema: semaglutide SGLT2i: Sodium-glucose co-transporter-2 inhibitor sita: sitagliptin SNAC: Sodium N-(8-[2-hydroxybenzoyl]amino)caprylate SU: Sulfonylurea t 1/2 : Terminal half-life T2D: Type 2 diabetes T max : Time to maximum concentration References Lau JL, Dunn MK

A complete pricing guide 5 GLP-1 trends to expect in 2026 Semaglutide dosing guidelines: a complete 2026 schedule Medical disclaimer: CagriSema is an investigational drug

When weight loss feels supported rather than rushed, results are more likely to last

When switching from one to the other, patients will need to check with their insurance provider or employer to find out what documentation is required for prior authorization

In: Berkowitz AL, eds